Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001689375-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-15 | TRDA | Doshi Dipal | CEO, Dir | S - Sale | $15.00 | -1,000 | 243.3K | -0.4% | -$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | S | D | 1,000 | $15.00 | 243,279 | D | — | — |